Associations between vitamin D and cardiovascular outcomes; Tehran Lipid and Glucose Study

Atherosclerosis

Volumn 218, Issue 1, 2011, Pages 238-242

  Hosseinpanah, Farhad ^a   Yarjanli, Masoumeh ^b   Sheikholeslami, Farhad ^c   Heibatollahi, Motahare ^a   Eskandary, Parvin Sarbakhsh ^a   Azizi, Fereidoun ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cardiovascular outcomes; Serum vitamin D; Tehran Lipid and Glucose Study

Indexed keywords

VITAMIN D;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

AGED; BLOOD GLUCOSE; CALCITRIOL; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; HUMANS; IRAN; LIPIDS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; TREATMENT OUTCOME; VITAMIN D;

EID: 80052269264     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.05.016     Document Type: Article

References (43)

1. Brown J., O'Connor G. Coronary heart disease and prevention in the United States. N Engl J Med 2010, 362:2150-2153.
2. Hadaegh F., Harati H., Ghanbarian A., Azizi F. Prevalence of coronary heart disease among Tehran adults: Tehran Lipid and Glucose Study. East Mediterr Health J 2009, 15.
3. Sarraf-Zadegan N., Sayed-Tabatabaei F., Bashardoost N., et al. The prevalence of coronary artery disease in an urban population in Isfahan, Iran. Acta Cardiol 1999, 54:257-263.
4. Prentice A.T. The emerging epidemic of obesity in developing countries. Int J Epidemiol 2006, 35:93-99.
5. Ôunpuu S., Negassa A., Yusuf S. INTERHEART: a global case-control study of risk factors for acute myocardial infarction. Am Heart J 2001, 141:711-721.
6. Yusuf S., Hawken S., Ôunpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952.
7. Dobnig H., Pilz S., Scharnagl H., et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008, 168:1340-1349.
8. Wang T.J., Pencina M.J., Booth S.L., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117:503-511.
9. Giovannucci E., Liu Y., Hollis B.W., Rimm E.B. 25-Hydroxyvitamin D and risk of myocardial infarction in men. Arch Intern Med 2008, 168:1174-1180.
10. Stumpf W., Sar M., Reid F., Tanaka Y., DeLuca H. Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science 1979, 206:1188-1190.
11. Pittas A., Lau J., Hu F., Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007, 92:2017-2029.
12. Zittermann A., Schleithoff S., Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 2005, 94:483-492.
13. Yc L. Vitamin D regulation of the renin-angiotensin system. J Cell Biochem 2003, 88:327-331.
14. Watson K., Abrolat M., Malone L., et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997, 96:1755-1760.
15. Carthy E., Yamashita W., Hsu A., Ooi B. 1,25-Dihydroxyvitamin D3 and rat vascular smooth muscle cell growth. Hypertension 1989, 13:954-959.
16. Simpson R., Hershey S., Nibbelink K. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J Steroid Biochem Mol Biol 2007, 103:521-524.
17. Borges A., Feres T., Vianna L., Paiva T. Effect of cholecalciferol treatment on the relaxant responses of spontaneously hypertensive rat arteries to acetylcholine. Hypertension 1999, 34:897-901.
18. Chleithoff S., Zittermann A., Tenderich G., Berthold H., Stehle P., Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006, 83:754-759.
19. Grimes D., Hindle E., Dyer T. Sunlight cholesterol and coronary heart disease. QJM 1996, 89:579-589.
20. Chiu K., Chu A., Go V., Saad M. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004, 79:820-825.
21. Li Y., Qiao G., Uskokovic M., Xiang W., Zheng W., Kong J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 2004, 89-90:387-392.
22. Scragg R., Jackson R., Holdaway I., Lim T., Beaglehole R. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol 1990, 19:559-563.
23. Pilz S., Dobnig H., Fischer J., et al. Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke 2008, 39:2611-2613.
24. Cigolini M., Iagulli M., Miconi V., Galiotto M., Lombardi S., Targher G. Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care 2006, 29:722-724.
25. Melamed M., Muntner P., Michos E., et al. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol 2008, 28:1179-1185.
26. Pilz S., März W., Wellnitz B., et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 2008, 93.
27. Pittas A., Chung M., Trikalinos T., et al. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 2010, 152:307-314.
28. Azizi F., Ghanbarian A., Momenan A., et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 2009, 10.
29. Hadaegh F., Harati H., Ghanbarian A., Azizi F. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Eur J Cardiovasc Prev Rehabil 2006, 13:571-577.
30. Lips P. Which circulating level of 25-hydroxyvitamin D is appropriate?. J Steroid Biochem Mol Biol 2004, 89-90:611-614.
31. Moradzadeh K., Larijani B., Keshtkar A.A., et al. Normative values of vitamin D among Iranian population: a population based study. Int J Osteoporos Metab Disord 2008, 1:8-15.
32. Lissner D., Mason R., Posen S. Stability of vitamin D metabolites in human blood serum and plasma. Clin Chem 1981, 27:773-774.
33. Vieth R., Bischoff-Ferrari H., Boucher B., et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 2007, 85:649-650.
34. Holick M. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
35. Forman J., Giovannucci E., Holmes M., et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007, 49:1063-1069.
36. Melamed M., Michos E., Post W., Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008, 168:1629-1637.
37. Kilkkinen A., Knekt P., Aro A., et al. Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol 2009, 170:1032-1039.
38. Boer Id, Tinker L., Connelly S., et al. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care 2008, 31:701-707.
39. Zittermann A., Frisch S., Berthold H., et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009, 89:1321-1327.
40. Margolis K., Ray R., Van Horn L., et al. Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial. Hypertension 2008, 52:847-855.
41. Giovannucci E., Liu Y., Hollis B., Rimm E. 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008.
42. Hsia J., Heiss G., Ren H., et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007, 115:846-854.
43. Hashmi J.P., Dutton O., Mavrodaris D., et al. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 2010, 65:225-236.